Receptor‐Triggered Peptide Self‐Assembly Enables Multivalent Recruitment of Endogenous Antibodies for Cancer Immunotherapy
ABSTRACT Monoclonal antibody–based immunotherapies have achieved remarkable clinical success but remain limited by variable patient responses, immune‐related toxicities, and the complexity of antibody production. Antibody‐recruiting molecules (ARMs) offer an alternative strategy by harnessing endogenous antibodies to i...